Related Experiment Video
Updated: Feb 9, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT
Xiaoqi Wang1, Guangyuan Li1,2, Sanjay Koul1
1Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
Abstract:
Pleckstrin homology-like domain family A member 2 (PHLDA2) is located within the tumor suppressor region of 11p15, and its expression is suppressed in several malignant tumor types. We recently identified PHLDA2 as a robustly induced, novel downstream target of oncogenic EGFR/ErbB2 signaling. In an immunohistochemical study, we find that PHLDA2 protein expression correlates positively with AKT activation in human lung cancers corroborating our data that PHLDA2 is induced upon oncogenic activation and might serve as a biomarker for AKT pathway activation. We show that PHLDA2 overexpression inhibits AKT phosphorylation while decreased PHLDA2 expression increases AKT activity. We further find that PHLDA2 competes with the PH domain of AKT for binding of membrane lipids, thereby directly inhibiting AKT translocation to the cellular membrane and subsequent activation. Indeed, PHLDA2 overexpression suppresses anchorage-independent cell growth and decreased PHLDA2 expression results in increased cell proliferation and reduced sensitivity to targeted agents of EGFR/ErbB2-driven cancers demonstrating functional relevance for this interaction. In summary, our studies demonstrate that PHLDA2 is strongly regulated by EGFR/ErbB2 signaling and inhibits cell proliferation via repressing AKT activation in lung cancers in a negative feedback loop. We highlight a novel action for PHLDA2 as a potential biomarker for AKT pathway activation.
Insights
Pleckstrin homology-like domain family A member 2 (PHLDA2) suppresses lung cancer growth by inhibiting AKT pathway activation, acting as a biomarker for this signaling cascade. PHLDA2 is induced by oncogenic EGFR/ErbB2 signaling.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Pleckstrin homology-like domain family A member 2 (PHLDA2) is a tumor suppressor gene. Its expression is reduced in various cancers.
- Epidermal Growth Factor Receptor (EGFR) and ErbB2 signaling pathways are frequently dysregulated in cancers, driving tumor growth.
- The AKT pathway is a critical mediator of cell survival and proliferation in cancer.
Purpose of the Study:
- To investigate the role of PHLDA2 in lung cancer.
- To determine the relationship between PHLDA2, EGFR/ErbB2 signaling, and AKT activation.
- To explore PHLDA2 as a potential biomarker for AKT pathway activation in lung cancer.
Main Methods:
- Immunohistochemical analysis of PHLDA2 and AKT activation in human lung cancer tissues.
- In vitro studies to assess the effects of PHLDA2 overexpression and knockdown on AKT phosphorylation and activity.
- Cellular assays to evaluate PHLDA2's impact on anchorage-independent growth, proliferation, and sensitivity to targeted therapies.
Main Results:
- PHLDA2 expression positively correlates with AKT activation in lung cancers.
- PHLDA2 overexpression inhibits AKT phosphorylation and membrane translocation, while PHLDA2 knockdown enhances AKT activity.
- PHLDA2 overexpression suppresses anchorage-independent growth, and its decreased expression increases proliferation and reduces sensitivity to EGFR/ErbB2-targeted agents.
Conclusions:
- PHLDA2 is a downstream target of oncogenic EGFR/ErbB2 signaling and negatively regulates AKT activation in lung cancer.
- PHLDA2 acts as a direct inhibitor of AKT by competing for membrane lipid binding, thus repressing cell proliferation.
- PHLDA2 serves as a potential biomarker for AKT pathway activation and a therapeutic target in EGFR/ErbB2-driven lung cancers.
Related Concept Videos
Cell Signaling Feedback Loops
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
PI3K/mTOR/AKT Signaling Pathway
Bacterial Signaling
What is Cell Signaling?
Positive and Negative Feedback Loops
Endocrine Signaling

